Tompkins Financial Corp lessened its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 9.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,716 shares of the financial services provider’s stock after selling 188 shares during the quarter. Tompkins Financial Corp’s holdings in MetLife were worth $141,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Virtu Financial LLC bought a new position in shares of MetLife during the 2nd quarter valued at about $1,362,000. Bradley Foster & Sargent Inc. CT raised its holdings in MetLife by 5.0% during the 2nd quarter. Bradley Foster & Sargent Inc. CT now owns 3,501 shares of the financial services provider’s stock worth $246,000 after buying an additional 166 shares during the period. Mercer Global Advisors Inc. ADV lifted its stake in MetLife by 0.5% in the second quarter. Mercer Global Advisors Inc. ADV now owns 62,120 shares of the financial services provider’s stock valued at $4,353,000 after buying an additional 317 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. boosted its holdings in shares of MetLife by 2.2% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 21,018 shares of the financial services provider’s stock valued at $1,475,000 after buying an additional 446 shares during the period. Finally, Vanguard Personalized Indexing Management LLC increased its position in shares of MetLife by 7.0% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 65,371 shares of the financial services provider’s stock worth $4,556,000 after acquiring an additional 4,280 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the stock. Piper Sandler boosted their price objective on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Jefferies Financial Group boosted their price target on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 27th. Wells Fargo & Company reduced their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research report on Tuesday. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, Barclays upped their price target on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $89.92.
MetLife Stock Performance
NYSE MET opened at $85.90 on Friday. The firm has a market capitalization of $59.48 billion, a P/E ratio of 17.32, a price-to-earnings-growth ratio of 0.59 and a beta of 1.07. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm’s fifty day moving average price is $83.19 and its two-hundred day moving average price is $79.24. MetLife, Inc. has a 1 year low of $64.61 and a 1 year high of $89.05.
MetLife Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a $0.545 dividend. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.54%. MetLife’s dividend payout ratio (DPR) is currently 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
- Trading Halts Explained
- Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.